HALIFAX, April 24 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,
announced today that it continues to build sales momentum, expand into new
sales territories, and extend its product reach in Eastern Europe. Building on
an initial distribution channel in Romania MedMira is expanding its footprint
in the region to include the Republic of Moldova and Ukraine. Together with
its regional distribution partner, S.C. Roned International S.R.L., MedMira
will bring MiraCare(TM) Rapid HIV Test to these markets immediately and begin
the approval process for Multiplo(TM) Rapid HBV/HIV/HCV Test.
